Notice of Change to NIAMS Acceptance of Diversity and Re-Entry Supplement Applications

Notice Number: NOT-AR-19-011

Key Dates
Release Date: August 30, 2018

Related Announcements

PA-18-906, Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
PA-18-592, Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed)

Issued by
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

This Notice is to inform the research community that NIAMS is amending its policy for applications submitted in response to PA-18-586, "Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)" and PA-18-592, "Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed)."

Effective immediately, NIAMS accepts and reviews applications on a continuous basis between October 1 and May 31. Applications received outside of these dates will be returned, but could be resubmitted during the during the next receipt period if appropriate.

Inquiries

Please direct all inquiries to:

Justine Buschman, M.S.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-496-4811
Email: NIAMSDiversityProgram@mail.nih.gov